Please find all related articles below.
November 20014 - Despite the existence of various pro-public health guidelines, Mr. Juncker’s Commission Programme gives cause for concern.
The European Commission President Mr. Juncker and First Vice-President Mr. Timmermans outlined the draft list of key initiatives that constitute the Commission Work Programme (CWP), with an aim for it to be adopted in Strasbourg on December 16.
What’s At Stake for Public Health in The CWP 2015?
Among the Commission’s priorities, (...)
November 2014 - The new Commission under President Jean-Claude Juncker officially took office on 1st November. EPHA has closely monitored the evaluation process of the new College of Commissioners and collected the health relevant commitments the Commissioners for Health and Food Safety; Internal Market, Industry, Entrepeneurship and SMEs; and Employment, Social Affairs, Skills and Labour Mobilty.
Vytenis Andriukatis, Commissioner for Health and Food Safety (EPHA evaluation of his (...)
The EU’s new economic governance framework requires, under Regulation No. 473/2013, that the countries of the euro area submit their draft budgetary plans to the European Commission each year by 15 October. In this document, EPHA provides a first-look analysis of the draft budgetary reports submitted this year.
This is the first analysis of the draft budgetary plans that EPHA has undertaken. The draft budgetary monitoring procedure is a crucial element of the EU’s economic (...)
Last week a joint consultation response, written by EPHA, Friends of the Earth, the European Women’s Lobby, Culture Action Europe and the European Association for the Education of Adults, was submitted to the European Commission.
The civil society response to the Commission’s consultation highlights the importance of moving beyond GDP in measuring the effectiveness of the Europe 2020 Strategy. GDP, it states, ’leads to short-termism, over-consumption, impoverishment of (...)
EPHA welcomes the Commission’s revision of the guidelines on Impact Assessment (IA) and the opportunity to contribute to this process via consultation. EPHA is able to offer suggestions for improving the way health impacts of EU policy are evaluated, and we highlight the need for IA to take account of the impact of EU policy upon NGOs and other third sector bodies. EPHA does not claim to have expertise in the practices of IA methodology, but rather has experience in the growing use of (...)
EPHA welcomes the Commission’s publication of comprehensive consultation guidelines. Smart regulation should mean fair and citizen-centred policy making that brings tangible benefits to the citizens of Europe and improves their quality of life. This involves greater use of evidence-based impact assessment and improving the consultation process.
The aim of the guidelines should be to ensure transparency and representativeness. Publishing consultation responses, as well as explanations (...)
Frans Timmermans performed very well in his hearing, seeming to convince the European Parliament that he was the right person to take on the designated portfolio. He presented himself as a pragmatic person. Responding to the question of MEP In’t Veld (Dutch liberal) whether he would be the “lapdog of governments or the champion of citizen’s rights”, Mr Timmermans replied that he would want to cooperate with everybody. His vision is to have a network of institutions, (...)
Below you can find EPHA’s response to the public consultation on the mid-term review of the Europe 2020 Strategy. EPHA believes that the Europe 2020 Strategy should be revised in order to better serve the public health interests of Europeans. Current targets do not invest enough in sustainable development despite its potential to create economic surplus in addition to social benefits. EPHA advocates the addition of more health targets in the Europe 2020 Strategy as well as more (...)
“Placing pharma policy in DG Enterprise was justified. It has traditionally been in DG Enterprise, but was moved to DG Sanco and has once again been instated as an Enterprise competence” said during her hearing Commissioner-designate Elzbieta Bienkowska.
By Dorota Sienkiewicz,Health Equity and Policy Coherence Coordinator, and Martyna Giedrojć, EPHA Policy Officer for Health Systems
The pharmaceutical industry is the biggest sector in the world. In terms of production, (...)
Brussels, 2 October 2014 - We are writing to support Member States who have already expressed their concerns on the decision of European Commission President Elect Jean-Claude Juncker to move the competence for medicinal products and health technologies from the Commissioner in charge of Health to the Commissioner in charge of Internal Market and Industry within the new Commission. We would like to ask for your full support to have that decision reversed.
Dear Head of States, Dear Prime (...)